Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Jul
18
2016
Can You Identify Your Trade Dress? Foley & Lardner LLP
Oct
31
2016
USPTO Again Proposes To Revise Duty Of Disclosure In View Of Therasense Foley & Lardner LLP
Jul
27
2020
PTAB Must Give Parties A Chance To Respond To New Grounds Foley & Lardner LLP
Aug
19
2020
PTAB’s Motion to Amend Pilot Program: Review of Initial Results Foley & Lardner LLP
Feb
20
2017
Federal Circuit Knocks Out Patents After CMB Challenge Foley & Lardner LLP
Mar
7
2017
Will Avastin Biosimilar Patent Dance Go On? Foley & Lardner LLP
Dec
15
2020
Arthrex Amicus Briefs – Novel Arguments for the Court To Consider Foley & Lardner LLP
Dec
30
2020
Arthrex’s Initial Merits Brief – Making the Case for Patent Judges as Principal Officers Foley & Lardner LLP
Jan
26
2021
Federal Circuit Denies Sipco’s Appeal of CBM Institution Foley & Lardner LLP
Feb
9
2021
USPTO Offers Relief for COVID-Related Delays in Submitting Priority Documents Foley & Lardner LLP
May
23
2017
CAFC Finds ANDA Infringement Despite Differences Between FDA Labeling And Claim Language Foley & Lardner LLP
Feb
16
2021
The Tools Used in Modern Business---Such As Videoconferencing---and the Social Media Culture Create Real Challenges to Protecting Trade Secrets Foley & Lardner LLP
Jun
22
2017
Is Congress Finally Getting Serious About Curtailing Design Patents in Auto Industry? Foley & Lardner LLP
Jul
11
2017
District Court Invalidates Dietary Supplement Patents On Motion To Dismiss Foley & Lardner LLP
Jul
17
2017
Why The Federal Circuit Revisited Written Description Foley & Lardner LLP
May
6
2015
Federal Circuit Keeps Sandoz Biosimilar Off The Market For Now Foley & Lardner LLP
Jun
2
2015
FTC’s $1.2 Billion Disgorgement Settlement With Cephalon: Heightened Scrutiny of Hatch-Waxman Settlements Foley & Lardner LLP
Jul
12
2022
Federal Circuit Reconsiders Written Description Support For Negative Limitation Foley & Lardner LLP
Jul
18
2022
Strategic IP for Protection of Product Manufacturers Foley & Lardner LLP
Aug
8
2022
USPTO Underscores Duty of Disclosure Pertaining To FDA Submissions Foley & Lardner LLP
Aug
22
2022
Building A Technological Moat: Strategic Use of Continuing Patent Applications Foley & Lardner LLP
Aug
24
2015
Protecting Diagnostic Innovation – Two Actor Infringement Liability Foley & Lardner LLP
Oct
18
2022
Federal Circuit Clarifies Conditions for Standard Essential Patents in LTE Technologies Foley & Lardner LLP
Sep
15
2015
Improving Patent Quality With International Collaborative Search Pilot Programs Foley & Lardner LLP
Jan
30
2023
Singapore: A Rising Tiger Economy for Startups and Venture Capital in Asia Foley & Lardner LLP
Jun
11
2018
USPTO Vanda Memo Emphasizes Patent Eligibility Of Method Of Treatment Claims Foley & Lardner LLP
May
15
2023
No Non-Competes for Lawyers? Trade Secret Misappropriation Lawsuits against Big Law Lawyers and Firm Management on the Rise Foley & Lardner LLP
Dec
15
2015
Biosimilar Pre-Marketing Notice Always Required Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins